Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Read

Showing results (551-560 of 556) with videos related to

Pageof 56
Sort By:
You have reached the last page of results.This site can display upto 556 results.
The New England Journal of Medicine|October 26, 2007
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancerMarshall R Posner, Diane M Hershock, Cesar R Blajman, et al.
Plos One|March 8, 2014
Comparison of illumina and 454 deep sequencing in participants failing raltegravir-based antiretroviral therapyJonathan Z Li, Brad Chapman, Patrick Charlebois, et al.
The Lancet. HIV|October 14, 2022
Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panelMaurine D Miner, Mark Hatherill, Vidya Mave, et al.
Ocular Immunology and Inflammation|April 15, 2025
Effectiveness of Frequently Used TNF Inhibitors vs. Conventional Immunosuppressive Therapies for Noninfectious UveitisSapna S Gangaputra, Craig W Newcomb, Gui-Shuang Ying, et al.
Ophthalmology|July 27, 2023
Use of Immunosuppression and the Risk of Subsequent Overall or Cancer MortalityJohn H Kempen, Craig W Newcomb, Terri L Washington, et al.
BMJ Oncology|January 31, 2025
Use of immunosuppression and subsequent cancer incidence: cohort studyJeanine M Buchanich, Craig W Newcomb, Terri L Washington, et al.
Pageof 56

Showing results (551-560 of 556) with videos related to

Sort By:
Pageof 56
You have reached the last page of results.This site can display upto 556 results.
The New England Journal of Medicine|October 26, 2007
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancerMarshall R Posner, Diane M Hershock, Cesar R Blajman, et al.
Plos One|March 8, 2014
Comparison of illumina and 454 deep sequencing in participants failing raltegravir-based antiretroviral therapyJonathan Z Li, Brad Chapman, Patrick Charlebois, et al.
The Lancet. HIV|October 14, 2022
Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panelMaurine D Miner, Mark Hatherill, Vidya Mave, et al.
Ocular Immunology and Inflammation|April 15, 2025
Effectiveness of Frequently Used TNF Inhibitors vs. Conventional Immunosuppressive Therapies for Noninfectious UveitisSapna S Gangaputra, Craig W Newcomb, Gui-Shuang Ying, et al.
Ophthalmology|July 27, 2023
Use of Immunosuppression and the Risk of Subsequent Overall or Cancer MortalityJohn H Kempen, Craig W Newcomb, Terri L Washington, et al.
BMJ Oncology|January 31, 2025
Use of immunosuppression and subsequent cancer incidence: cohort studyJeanine M Buchanich, Craig W Newcomb, Terri L Washington, et al.
Pageof 56